NFKB1 and neoplasm: An upregulation of IL-6 has been reported in several kinds of malignancies, and works as a tumor promotor in the tumor microenvironment through multiple pathways including the NF-kB and MAPK/ERK signaling pathway, including promotion of proliferation, angiogenesis and invasiveness [37].